Premium
P1‐026: Biomarker and long‐term effects of cholinesterase inhibitors in Alzheimer's disease and MCI
Author(s) -
Davis Bonnie
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2012.05.301
Subject(s) - galantamine , rivastigmine , donepezil , placebo , cholinesterase , acetylcholinesterase , medicine , biomarker , randomized controlled trial , dementia , alzheimer's disease , psychology , disease , chemistry , pathology , biochemistry , alternative medicine , enzyme